Skip to content

The Effectiveness and Safety of Acupuncture for Uremic Pruritus in Maintenance Hemodialysis Patients

The Effectiveness and Safety of Acupuncture for Uremic Pruritus in Maintenance Hemodialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000749
Enrollment
Unknown
Registered
2026-03-27
Start date
2025-02-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uremic Pruritus (Uremic Pruritus in Maintenance Hemodialysis Patients)

Interventions

Acupuncture Treatment Group:Acupuncture at Quchi, Xuehai, Hegu, Zusanli, Sanyinjiao, Shaohai, Yuye,angu, Guanyuan, Qihai and other ten acupoints. And oral loratadine.
Blank Control Group:Oral loratadine

Sponsors

The Second People's Hospital of Yibin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18 and 85 years; (2) Have undergone maintenance hemodialysis for more than 3 months, with a dialysis frequency of three times per week; (3) Have experienced pruritus for over 6 months, meeting the diagnostic criteria for uremic pruritus; (4) Patients have provided signed informed consent and fully understand the trial details.

Exclusion criteria

Exclusion criteria: (1) Intolerance to acupuncture treatment, such as fainting during needle insertion; (2) Pruritus caused by other diseases; (3) Local skin infections, ulcers, tumors, or rashes at the acupuncture sites; (4) History of spontaneous bleeding or bleeding tendency, or presence of skin petechiae or purpura; (5) Inability to cooperate in completing assessments (e.g., due to encephalopathy, mental disorders, etc.); (6) Participation in any other drug or medical device clinical trials within the past month; (7) Use of any medications affecting pruritus within the past week; (8) Women who are pregnant or breastfeeding; (9) Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS);

Secondary

MeasureTime frame
Laboratory parameters;Every week Skindex-10;Every week 5-D;Every week PSQI;Every week Visual Analog Scale (VAS);

Countries

China

Contacts

Public ContactQianrong Tian

The Second People's Hospital of Yibin

215603445@qq.com13890980292

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026